Abstract
Any person travelling in countries where yellow fever (YF) is endemic and without presenting contra-indication for the vaccination against YF may be vaccinated. This vaccination can very rarely induce a potentially lethal neurotropic or viscerotropic disease. In severely immunodeficient patients, the vaccination is contra-indicated because postvaccinal encephalitis may occur after the vaccination, due to vaccine strain pathogenecity. It is important to evaluate the general health status in elderly individuals before vaccinating because of the increased risk of viscerotropic disease in people of 60 years of age and over. Pregnant women should not be vaccinated, except if departure to an endemic zone is unavoidable. YF vaccinatio is contra-indicated for newborns under six months of age. Solid organ grafts, congenital immunodeficiency, leukemia, lymphoma, cancer, and immunosuppressive treatments are contra-indications for this vaccination. Nevertheless, YF immunization is possible after a bone marrow graft and a two-year period without graft-versus-host disease or immunosuppressive treatment. There is no data to support that immunization of the dono prior to the graft could confer protection against yellow fever to the recipient. ...Continue Reading
References
Jan 1, 1995·Immunology Today·C FranceschiA Cossarizza
May 1, 1993·Transactions of the Royal Society of Tropical Medicine and Hygiene·A NasidiS Wali
Jun 1, 1997·Biologicals : Journal of the International Association of Biological Standardization·L Loutan
Jan 14, 1998·The Pediatric Infectious Disease Journal·T S SibaillyA E Greenberg
Apr 10, 1999·AIDS·A Desgrées du LoûF Dabis
Jul 21, 2001·Lancet·M MartinM S Cetron
Oct 6, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K LederM E Wilson
Nov 3, 2001·Journal of the American College of Cardiology·J A de Lemos, E Braunwald
Dec 19, 2001·Emerging Infectious Diseases·M MartinUNKNOWN GeoSentinel Yellow Fever Working Group
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas P Monath, Martin S Cetron
Apr 25, 2003·International Journal of Cancer. Journal International Du Cancer·Eric A Engels, Ruth M Pfeiffer
Apr 26, 2003·Mechanisms of Ageing and Development·Alexei A Romanyukha, Anatoli I Yashin
Jul 15, 2003·Clinical Microbiology Reviews·Andrea DuchiniPaul J Pockros
Oct 3, 2003·Pediatrics·Elena E PerezKathleen E Sullivan
Apr 13, 2004·AIDS·Pierre TattevinChristian Michelet
Apr 20, 2004·European Journal of Haematology·R GowdaS T Green
Jun 23, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Edina H MoylettWilliam T Shearer
Sep 15, 2004·Lancet·Rachel Barwick Eidex, UNKNOWN Yellow Fever Vaccine Safety Working Group
Sep 24, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Kathleen E Sullivan
Nov 9, 2004·Vaccine·Julia FitznerDenis Coulombier
Feb 11, 2005·Infectious Disease Clinics of North America·Anthony A MarfinMartin S Cetron
Feb 12, 2005·Vaccine·Chiara AzzariAlberto Vierucci
Mar 8, 2005·Bone Marrow Transplantation·P LjungmanUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Apr 20, 2005·Vaccine·Alena Y KhromavaUNKNOWN Yellow Fever Vaccine Safety Working Group
Oct 21, 2005·Vaccine·C E S SuzanoUNKNOWN Campinas Group on Yellow Fever Immunization during Pregnancy
Oct 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nina Singh, John R Perfect
Citations
Mar 25, 2009·Expert Opinion on Drug Safety·Cristina Domingo, Matthias Niedrig
Sep 6, 2013·The American Journal of Tropical Medicine and Hygiene·Eduardo GotuzzoErika Córdova
Apr 25, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C T RiegerUNKNOWN German Society of Hematology and Medical Oncology Infectious Diseases Working Group (AGIHO)
Jun 11, 2010·Arthritis Care & Research·Morton ScheinbergRodrigo Aires Lima